Brief: Eurofins Genomics Adopts Olink® Technology To Advance Proteomics Research And Accelerate Precision Medicine Programs
Olink Holding AB (publ) OLK.O :
* EUROFINS GENOMICS ADOPTS OLINK® TECHNOLOGY TO ADVANCE
PROTEOMICS
RESEARCH AND ACCELERATE PRECISION MEDICINE PROGRAMS
Source text for Eikon: ID:nGNX6tlMrq
Further company coverage: OLK.O
Recent news on Olink Holding AB (publ)
See all newsBrief: Olink Announces Receipt Of CMA Clearance For Proposed Acquisition By Thermo Fisher
UK's competition regulator clears $3.1 bln Thermo Fisher Scientific-Olink deal
Competition and Mkts - Merger Update : Thermo Fisher / Olink
Olink Holding AB (publ) reports results for the quarter ended in March - Earnings Summary
UK's CMA kicks off probe into Thermo Fisher-Olink deal